SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-03-01
|
Series: | Breast |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977623000826 |
_version_ | 1797869898143105024 |
---|---|
author | S. Tolaney |
author_facet | S. Tolaney |
author_sort | S. Tolaney |
collection | DOAJ |
first_indexed | 2024-04-10T00:19:49Z |
format | Article |
id | doaj.art-4b024b749db64f8fafd5cb624ca87dfc |
institution | Directory Open Access Journal |
issn | 1532-3080 |
language | English |
last_indexed | 2024-04-10T00:19:49Z |
publishDate | 2023-03-01 |
publisher | Elsevier |
record_format | Article |
series | Breast |
spelling | doaj.art-4b024b749db64f8fafd5cb624ca87dfc2023-03-16T05:01:40ZengElsevierBreast1532-30802023-03-0168S3SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs?S. Tolaneyhttp://www.sciencedirect.com/science/article/pii/S0960977623000826 |
spellingShingle | S. Tolaney SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs? Breast |
title | SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs? |
title_full | SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs? |
title_fullStr | SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs? |
title_full_unstemmed | SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs? |
title_short | SL 1 The future of innovation: Why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs? |
title_sort | sl 1 the future of innovation why arewe conducting clinical trials in countries that are unlikely to be able to afford innovative drugs |
url | http://www.sciencedirect.com/science/article/pii/S0960977623000826 |
work_keys_str_mv | AT stolaney sl1thefutureofinnovationwhyareweconductingclinicaltrialsincountriesthatareunlikelytobeabletoaffordinnovativedrugs |